» Articles » PMID: 10498587

In Utero Hematopoietic Stem Cell Transplantation: Ontogenic Opportunities and Biologic Barriers

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1999 Sep 25
PMID 10498587
Citations 44
Authors
Affiliations
Soon will be listed here.
Citing Articles

Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation.

Riley J, Berkowitz C, Luks V, Dave A, Cyril-Olutayo M, Pogoriler J Blood Adv. 2024; 8(17):4523-4538.

PMID: 38941538 PMC: 11395771. DOI: 10.1182/bloodadvances.2023012247.


Fetal gene therapy.

Waddington S, Peranteau W, Rahim A, Boyle A, Kurian M, Gissen P J Inherit Metab Dis. 2023; 47(1):192-210.

PMID: 37470194 PMC: 10799196. DOI: 10.1002/jimd.12659.


Experimental and clinical progress of in utero hematopoietic cell transplantation therapy for congenital disorders.

Shi C, Pan L, Hu Z Front Pharmacol. 2022; 13:851375.

PMID: 36120324 PMC: 9478511. DOI: 10.3389/fphar.2022.851375.


Immunological Consequences of Exposure to Foreign Antigens.

Chen J Front Immunol. 2021; 12:638435.

PMID: 33936052 PMC: 8082100. DOI: 10.3389/fimmu.2021.638435.


Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System.

Saenz de Villaverde Cortabarria A, Makhoul L, Strouboulis J, Lombardi G, Oteng-Ntim E, Shangaris P Front Cell Dev Biol. 2021; 8:624477.

PMID: 33553164 PMC: 7862553. DOI: 10.3389/fcell.2020.624477.